Symbiomix is a late-stage, privately-held biopharmaceutical company developing innovative medicines for serious womenвАЩs health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the worldвАЩs leading healthcare venture capital firms, OrbiMed,...